stop_circleTerminated/Withdrawn
Transcatheter Aortic Valve Replacement
Bayer Identifier:
17938
ClinicalTrials.gov Identifier:
EudraCT Number:
EU CT Number:
Not Available
Global study comparing a rivAroxaban-based antithrombotic strategy to an antipLatelet-based strategy after transcatheter aortIc vaLve rEplacement to Optimize clinical outcomes
Trial purpose
To assess whether a rivaroxaban-based anticoagulation strategy, following successful TAVR, compared to an antiplatelet-based strategy, is superior in reducing death or first thromboembolic events (DTE).
To assess the primary bleeding events (PBE) of the rivaroxaban-based strategy compared to an antiplatelet-based strategy, following TAVR.
To assess the primary bleeding events (PBE) of the rivaroxaban-based strategy compared to an antiplatelet-based strategy, following TAVR.
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
1653Trial Dates
December 2015 - November 2018Phase
Phase 3Could I Receive a placebo
NoProducts
Xarelto (Rivaroxaban, BAY59-7939)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Graz, 8036, Austria | |
Completed | Wien, 1090, Austria | |
Completed | Wien, 1130, Austria | |
Completed | Wels, 4600, Austria | |
Completed | Salzburg, 5020, Austria | |
Completed | Linz, 4020, Austria | |
Completed | Brno, 656 91, Czech Republic | |
Completed | Bad Nauheim, 61231, Germany | |
Completed | Bad Berka, 99437, Germany | |
Completed | Bad Neustadt, 97616, Germany | |
Completed | Bad Segeberg, 23795, Germany | |
Completed | Erlangen, 91054, Germany | |
Completed | Berlin, 10117, Germany | |
Completed | Magdeburg, 39120, Germany | |
Completed | Mainz, 55131, Germany | |
Completed | Regensburg, 93042, Germany | |
Completed | Bonn, 53105, Germany | |
Withdrawn | Universitätsklinikum Heidelberg | Heidelberg, 69115, Germany |
Completed | Köln, 50924, Germany | |
Completed | Lahr, 77033, Germany | |
Completed | München, 80331, Germany | |
Completed | Rotenburg a.d. Fulda, 36199, Germany | |
Completed | Tübingen, 72076, Germany | |
Completed | Berlin, 12200, Germany | |
Completed | Bern, 3010, Switzerland | |
Completed | Basel, 4056, Switzerland | |
Completed | Luzern, 6000, Switzerland | |
Completed | Zürich, 8091, Switzerland | |
Completed | Madrid, 28046, Spain | |
Completed | Oviedo, 33011, Spain | |
Completed | Málaga, 29010, Spain | |
Completed | Barcelona, 08036, Spain | |
Completed | L'Hospitalet de Llobregat, 08907, Spain | |
Completed | Berlin, 13353, Germany | |
Completed | Düsseldorf, 40225, Germany | |
Completed | Hamburg, 20246, Germany | |
Completed | Hannover, 30625, Germany | |
Withdrawn | Marburg, 35043, Germany | |
Completed | Neuss, 41464, Germany | |
Withdrawn | SHG-Kliniken Völklingen | Völklingen, 66333, Germany |
Recruiting | Fulda, 36043, Germany | |
Completed | BREST, 29609, France | |
Completed | Praha 10, 10034, Czech Republic | |
Completed | Praha 4, 140 21, Czech Republic | |
Withdrawn | Olomouc, 775 20, Czech Republic | |
Completed | Bielsko-Biala, 43-316, Poland | |
Completed | Warszawa, 04-628, Poland | |
Completed | Warszawa, 02-097, Poland | |
Completed | Brighton, BN2 5BE, United Kingdom | |
Completed | Leeds, LS1 3EX, United Kingdom | |
Completed | Leicester, LE3 9QP, United Kingdom | |
Completed | London, SE1 7EH, United Kingdom | |
Completed | Belfast, BT12 6BA, United Kingdom | |
Withdrawn | Birmingham, B15 2TH, United Kingdom | |
Completed | Edinburgh, EH16 4SA, United Kingdom | |
Completed | Blackpool, FY3 8NR, United Kingdom | |
Completed | Wien, 1160, Austria | |
Recruiting | Krefeld, 47805, Germany | |
Completed | Freiburg, 79106, Germany | |
Completed | Leipzig, 04289, Germany | |
Completed | Kiel, 24105, Germany | |
Completed | New York, 10029, United States | |
Completed | Catania, 95124, Italy | |
Completed | Milano, 20162, Italy | |
Completed | Charlottesville, 22908, United States | |
Completed | Philadelphia, 19104, United States | |
Completed | Plano, 75093, United States | |
Completed | Chicago, 60611, United States | |
Withdrawn | Baltimore, 21287-6568, United States | |
Completed | Baltimore, 21201, United States | |
Completed | Burlington, 05401, United States | |
Completed | Kansas City, 64111, United States | |
Completed | LIEGE, 4000, Belgium | |
Completed | HASSELT, 3500, Belgium | |
Completed | GENK, 3600, Belgium | |
Completed | Bergamo, 24127, Italy | |
Completed | Milano, 20089, Italy | |
Completed | Padova, 35128, Italy | |
Completed | Milano, 20132, Italy | |
Withdrawn | Pavia, 27100, Italy | |
Completed | Pisa, 56124, Italy | |
Completed | Winston-Salem, 27157-1082, United States | |
Completed | Evanston, 60201, United States | |
Withdrawn | Springfield, 62769, United States | |
Completed | Roslyn, 11576, United States | |
Completed | Houston, 77030-1501, United States | |
Withdrawn | Valhalla, 10595, United States | |
Completed | Southampton, SO16 6YD, United Kingdom | |
Completed | Newcastle Upon Tyne, NE7 7DN, United Kingdom | |
Completed | Oxford, OX9 3DU, United Kingdom | |
Completed | London, SE5 9RS, United Kingdom | |
Completed | AMSTERDAM, 1105 AZ, Netherlands | |
Withdrawn | AMSTERDAM, 1091 AC, Netherlands | |
Withdrawn | EINDHOVEN, 5623 EJ, Netherlands | |
Completed | ROTTERDAM, 3015 CE, Netherlands | |
Completed | BREDA, 4818 CK, Netherlands | |
Completed | Copenhagen, DK-2100, Denmark | |
Completed | Odense C, DK-5000, Denmark | |
Completed | Oslo, 0424, Norway | |
Completed | Tromsø, 9038, Norway | |
Completed | Bergen, N-5021, Norway | |
Completed | TOULOUSE, 31300, France | |
Completed | Chambray-lès-Tours, 37170, France | |
Withdrawn | CRETEIL, 94010, France | |
Completed | Angers, 49100, France | |
Completed | LILLE, 59000, France | |
Withdrawn | Stockholm, 171 76, Sweden | |
Completed | Uppsala, 751 85, Sweden | |
Completed | Newmarket, L3Y 2P7, Canada | |
Completed | Edmonton, T6G 2B7, Canada | |
Completed | Toronto, M5G 2C4, Canada | |
Completed | Vancouver, V6A 1Y6, Canada | |
Completed | Victoria, V8R 4R2, Canada | |
Not yet recruiting | Seoul, 06351, Korea, Republic Of | |
Not yet recruiting | Seoul, 110-744, Korea, Republic Of | |
Not yet recruiting | Seoul, 06591, Korea, Republic Of | |
Not yet recruiting | Seoul, 120-752, Korea, Republic Of | |
Completed | Houston, 77030, United States | |
Completed | Washington, 20010, United States | |
Completed | Cincinnati, 45219, United States | |
Withdrawn | Albany, 12208, United States | |
Withdrawn | St. Louis, 63110, United States | |
Completed | Detroit, 48202, United States | |
Withdrawn | New Orleans, 70121, United States | |
Completed | Miami, 33136, United States | |
Completed | Clearwater, 33756, United States | |
Completed | Atlanta, 30322, United States | |
Completed | Wilkes-Barre, 18711-3752, United States | |
Completed | Manhasset, 11030-3876, United States | |
Withdrawn | Boston, 02115-6195, United States | |
Completed | Los Angeles, 90048-0750, United States | |
Withdrawn | Los Angeles, 90027, United States | |
Completed | Minneapolis, 55407, United States | |
Withdrawn | New York, 10032, United States | |
Completed | München, 81925, Germany | |
Completed | Frankfurt, 60389, Germany | |
Completed | Dortmund, 44137, Germany | |
Completed | Halifax, B3H 3A7, Canada | |
Completed | Toronto, M4N 3M5, Canada | |
Completed | Cleveland, 44195, United States | |
Completed | Morristown, 07962, United States | |
Completed | Montreal, H1T 1C8, Canada | |
Withdrawn | Saint John, E2L 4M2, Canada | |
Completed | Aachen, 52074, Germany | |
Completed | Ulm, 89081, Germany | |
Withdrawn | Rochester, 55905, United States | |
Withdrawn | Columbus, 43214, United States | |
Completed | Boston, 02215, United States | |
Withdrawn | Richmond, 23226-1907, United States | |
Completed | Winnipeg, R2H 2A6, Canada | |
Withdrawn | La Jolla, 92037, United States | |
Withdrawn | Rochester, 14642, United States | |
Completed | Jacksonville, 32209, United States | |
Withdrawn | Liverpool, 13088, United States | |
Withdrawn | Birmingham, 35294, United States | |
Completed | Aarhus N, 8200, Denmark | |
Completed | Homburg, 66424, Germany | |
Completed | Konstanz, 78464, Germany | |
Withdrawn | New York, 10016-4576, United States | |
Completed | Tacoma, 98405, United States | |
Completed | Temple, 76508, United States | |
Completed | West Des Moines, 50266, United States | |
Completed | Falls Church, 22042-3300, United States | |
Withdrawn | Danville, 17822-2001, United States | |
Completed | München, 80636, Germany | |
Completed | Lugano, 6900, Switzerland | |
Withdrawn | Würzburg, 97080, Germany | |
Withdrawn | Hamburg, 20099, Germany | |
Completed | Bremen, 28277, Germany | |
Withdrawn | Nottingham, NG5 1PB, United Kingdom | |
Terminated | PARIS, 75014, France | |
Completed | Paris, 75018, France |
Primary Outcome
- Number of subjects with death or adjudicated thromboembolic event (DTE)Death or first adjudicated thromboembolic event (DTE), defined as composite of all-cause death, any stroke, myocardial infarction (MI), symptomatic valve thrombosis, pulmonary embolism (PE), deep vein thrombosis (DVT), and non-central nervous system (CNS) systemic embolism (per adjudication).date_rangeTime Frame:From randomization until end of study medication + 2 daysenhanced_encryptionNoSafety Issue:
- Number of subjects with death or adjudicated thromboembolic event (DTE)Death or first adjudicated thromboembolic event (DTE), defined as composite of all-cause death, any stroke, myocardial infarction (MI), symptomatic valve thrombosis, pulmonary embolism (PE), deep vein thrombosis (DVT), and non-central nervous system (CNS) systemic embolism (per adjudication).date_rangeTime Frame:From randomization until efficacy cut-off date (13-Aug-2018)enhanced_encryptionYesSafety Issue:
- Number of participants with primary bleeding event (PBE)PBE is defined according to VARC(Valve Academic Research Consortium) definitions as the adjudicated composite of: Life-threatening, disabling or major bleeding.date_rangeTime Frame:From randomization until efficacy cut-off date (13-Aug-2018)
Secondary Outcome
- Number of participants with cardiovascular death or thromboembolic eventComposite of CV-death, any stroke, myocardial infarction (MI), symptomatic valve thrombosis, pulmonary embolism (PE), deep vein thrombosis (DVT), and non-central nervous system (CNS) systemic embolism (per adjudication).date_rangeTime Frame:From randomization until efficacy cut-off date (13-Aug-2018)enhanced_encryptionNoSafety Issue:
- Number of participants with Net-clinical benefitThe net-clinical-benefit defined as the adjudicated composite of all-cause death, any stroke, myocardial infarction, symptomatic valve thrombosis, pulmonary embolism, deep vein thrombosis, non-CNS systemic embolism (efficacy); VARC life-threatening, disabling and VARC major bleeds (safety).date_rangeTime Frame:From randomization until efficacy cut-off date (13-Aug-2018)enhanced_encryptionYesSafety Issue:
- Number of participants with TIMI (Thrombolysis In Myocardial Infarction) major / minor bleedsComposite of TIMI major and minor bleedingsdate_rangeTime Frame:From randomization until efficacy cut-off date (13 August 2018)
- Number of participants with ISTH (International Society on Thrombosis and Haemostasis) major bleedsISTH major bleedsdate_rangeTime Frame:From randomization until efficacy cut-off date (13 August 2018)
- Number of participants with composite bleeding endpoint of BARC (Bleeding Academic Research Consortium) 2, 3, or 5 bleedsComposite of BARC 2,3 or 5 bleedingsdate_rangeTime Frame:From randomization until efficacy cut-off date (13 August 2018)enhanced_encryptionYesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
PreventionAllocation
RandomizedBlinding
Open LabelAssignment
Parallel AssignmentTrial Arms
2